Prolonged treatment with the β3-adrenergic agonist CL 316243 induced adipose tissue remodeling in rat but not in guinea pig: 1) fat store depletion and desensitization of β-adrenergic responses

Journal of Physiology and Biochemistry

Volumn 62, Issue 2, 2006, Pages 89-99

  Ferrand, C ^a   Redonnet, A ^a   Prevot D ^b   Carpene C ^b   Atgié, Clause ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

Adipose tissue; Glucose transport; Insulin; Lipolysis; adrenoceptor

Indexed keywords

4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; 5 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL] 1,3 BENZODIOXOLE 2,2 DICARBOXYLIC ACID; ANTIOBESITY AGENT; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOPINDOLOL I 125; DOBUTAMINE; FORSKOLIN; GLUCOSE; INSULIN; MESSENGER RNA; NORADRENALIN; PROCATEROL; 1,3 DIOXOLANE DERIVATIVE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOIODOPINDOLOL; ETHANOLAMINE DERIVATIVE;

ADIPOCYTE; ADIPOSE TISSUE; ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BROWN ADIPOSE TISSUE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE TRANSPORT; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; LIPOLYSIS; MALE; NONHUMAN; OBESITY; OSMOTIC MINIPUMP; RAT; RECEPTOR DOWN REGULATION; SPECIES DIFFERENCE; VISCERA; WEIGHT GAIN; WEIGHT REDUCTION; WHITE ADIPOSE TISSUE; ANIMAL; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; GUINEA PIG; METABOLISM; PATHOLOGY; PHYSIOLOGY; WHITE ADIPOCYTE; WISTAR RAT;

ANIMALIA; CAVIA; RATTUS; RATTUS NORVEGICUS; RODENTIA;

ADIPOCYTES, WHITE; ADIPOSE TISSUE; ADRENERGIC BETA-AGONISTS; ANIMALS; DIOXOLES; DOWN-REGULATION; ETHANOLAMINES; GUINEA PIGS; INSULIN; IODOCYANOPINDOLOL; MALE; NOREPINEPHRINE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-3;

EID: 33845526084     PISSN: 11387548     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03174070     Document Type: Article

References (36)

1. Abe, H., Minokoshi, Y., and Shimazu, T. (1993): J. Endocrinol., 139, 479-486.
2. Arch, J. R., Ainsworth, A. T., Cawthorne, M. A., Percy, V., Sennit, M. V., Thody, E., Wilson, C., and Wilson, S. (1984): Nature, 309, 163-165.
3. Atgié, C., D'Allaire, F., and Bukowiecki, L. J. (1997): Am, J. Physiol. Cell Physiol., 42, C1136-C1142.
4. Atgié, C., Faintrenie, G., Carpéné, C., Bukowiecki, L. J., and Géloën, A. (1998): Comp. Biochem. Physiol., 119A, 629-636.
5. Atgié, C., Tavernier, G., D'Allaire, F., Bengtsson, T., Marti, L., Carpéné, C., Lafontan, M., Bukowiecki, L. J. and Lagin, D. (1996): Am. J. Physiol., 271, R1729-R1738.
6. Bairras, C., Ferrand, C., and Atgié, C. (2003): J. Physiol. Biochem., 59, 161-168.
7. Bloom, J. D., Dutia, M. D., Johnson, B. D., Wissner, A., Burns, M. G., Largis, E. E., Dolan, J. A., and Claus, T. H. (1992): J. Med. Chem., 35, 3081-3084.
8. Bout, S., Visentin, V., Prévot, D., and Carpéné, C. (2003) J. Physiol. Biochem., 59, 169-175.
9. Carpéné, C., Ambid, L., and Lafontan, M. (1994): Am. J. Physiol., 266, R896-R904.
10. Carpéné, C., Chalaux, E., Lizarbe, M., Estrada, A., Mora, C., Palacin, M., Zorzano, A., Lafontan, M., and Testar, X. (1993): Biochem. J., 296, 99-105.
11. Chaudry, A., MacKenzie, R. G., Georgic, L. M., and Granneman, J. G. (1994): Cell Signalling, 6, 457-465.
12. Duffaut, C., Bout, S., Prévot, D., Martí, L., Testar, X., Zorzano, A. and Carpéné, C. (2006): J. Physiol. Biochem., 62, 101-112.
13. Granneman, J. G. (1995): Cell. Signal., 7, 9-15.
14. Granneman, J. G., Li, P., Zhu, Z., and Lu. Y. (2005): Am. J. Physiol. Endocrinol. Metab., 289, E608-E616.
15. Green, A. R., Carroll, R. M., and Dobias, S. B. (1996): Am. J. Physiol., 271, E271-E276.
16. Hausdorff, W. P., Caron, M. G., and Lefkowitz. (1990): Fed. Am. Soc. Exp. Biol., 4, 2881-2891.
17. Himms-Hagens, J. J., Cui, J., Danforth, E., Taajes, D., Langs, S., Waters, B., and Claus, T. (1994): Am. J. Physiol., 266, R1371-R1382.
18. Howe, R. (1993): Drugs of the future, 18, 529-549.
19. Issad, T., Combettes, M., Ferré, P. (1995) Eur. J. Biochem., 234:108-115.
20. Jost, M. M., Jost, P., Klein, J., and Klein, H. H. (2005): Exp. Clin. Endocrinol. Diabetes, 113, 418-422.
21. Lafontan, M. and Berlan, M. (1993): J. Lipid Res., 34, 1057-1091.
22. Lamas, O., Martínez, J.A., and Marti, A. (2003): J. Physiol. Biochem., 59, 183-192.
23. Ligget, S. B., Freedman, N. J., Schwinn, D. A. and Lefkowitz, R. J. (1993): Proc. Natl. Acad. Sci., 90, 3665-3669.
24. Lipworth, B.J. (1996): Br. J. Clin. Pharmacol., 42: 291-300.
25. Liu, Y. L., Cawthorne, M. A., and Stock, M. J. (1996): A J. Pharmacol., 117, 1355-1361.
26. Lönnqvist, F., Krief, S., Strosberg, A. D., Nyberg, B., Emorine, L. J., and Arner, P. (1993): Br. J. Pharmacol., 110, 929-936.
27. Milagro, F. I., Gómez-Ambrosi, J., Martínez-Anso, E., and Martinez, J. A. (1999): J. Physiol. Biochem., 55, 25-31.
28. Moody, A. J., Stan, A. M., and Gliemann, J. (1974): Horm. Metab, Res., 6, 12-16.
29. Nantel, F., Bonin, H., Emorine, L. J., Zilberfarb, V., Strosberg, A. D., Bouvier, M., Marullo, S. (t993): Mol. Pharmacol., 43, 548-555.
30. Nantel, F., Bonnin, H., Emorine, L. J., Zilberfarb, V., Strosberg, A. D., Bouvier, M. and Marullo, S. (1993): Mol. Pharmacol., 43, 548-555.
31. Pott, C., Brixius, K., Bloch, W., Ziskoven, C., Napp, A., and Schwinger, R. H. (2006): Pharmazie, 61, 255-260.
32. Sawa, M., and Harada, H. Curr. Med. Chem. (2006): 13, 25-37.
33. Strosberg, A. D., and Pietri-Rouxel. (1996): Trends Pharmacol. Sci., 17, 373-381.
34. Susulic, VS, Frederic, RC, Lawitts, J., Tozzo, E., Kahn, B. B., Harper, M. E., Himms-Hagen, J., Flier, J. S., and Lowell, B. B. (1995): J. Biol. Chem., 270, 29483-29492.
35. White, C. L., Ishihara, Y., Doston, T. L., Hughes, D. A., Bray, G. A., and York, D. A. (2004): Physiol. Behav., 82, 489-496.
36. Yoshida, T., Sakane, N., Wakabayashi, T., Umekawa, T., and Kondo, M. (1994): Life Sci., 54, 491-498.